Aim Rule 26
Checklist and Guide for the Compliance with AIM Rule 26The London Stock Exchange publishes specific rules for companies listed on its Alternative Investment Market (the AIM Rules for Companies), including requirements for disclosure of particular information on the website of AIM listed companies (Rule 26). These rules require different disclosure methodologies to those required under ASX listing rules and Corporations Act 2001 requirements. Rule 26 is targeted at ensuring that investors and potential investors can access a minimum level of information about an AIM company at all times, requires an AIM company to maintain a website on which key company information must be disclosed and kept up to date.
The following table summarises and provides links to the information required by AIM rule 26:
| Information Facet | Details or where located on the Arana website www.arana.com |
| A description of its business | Refer to: Company Overview Product Pipeline |
| The names of its directors and
brief biographical details of each, as would normally be included in an admission document; |
Refer to: Arana Board |
| A description of the responsibilities of the members of the board of directors and details of any committees of the board of directors and their responsibilities; | Refer to: Corporate Governance Statement sections for links to charters of the various Board Committees, comprising: - Board charter - Audit and Compliance committee charter - Remuneration committee charter - Nominations committee charter |
| Its country of incorporation and main country of operation | Arana is incorporated in Australia, which is also the main country of operation for the Arana group. |
| Where the AIM company is not incorporated in the UK, a statement that the rights of shareholders may be different from the rights of shareholders in a UK incorporated company; | Arana is incorporated under, and is subject to, Australian corporations and securities legislation, including the Corporations Act 2001 and related legislation and regulations. The respective rights of Arana’s shareholders may be different from the rights of shareholders of companies incorporated in the United Kingdom and other non-Australian jurisdictions. |
| Its current constitutional documents (e.g. its articles of association); | Refer to: Constitution |
| Details of any other exchanges or trading platforms on which the AIM company has applied or agreed to have any of its securities (including its AIM securities) admitted or traded; |
Arana has been listed on the Australian Securities Exchange www.asx.com.au since 1986 and on AIM since December 2006 |
| The number of AIM securities in issue (noting any held as treasury shares) and, insofar as it is aware, the percentage of AIM securities that is not in public hands together with the identity and percentage holdings of its significant shareholders. This information should be updated at least every 6 months | As at 20 December 2007 Arana had on issue 234,986,037 ordinary shares. Significant shareholders identified as at that date comprise: - Start-up Australia Ventures Pty Ltd (Bioventures Aust P/Ship A/C) with 22,433,969 shares (9.55% of total issued capital) - Citicorp Nominees Pty Ltd with 14,703,152 shares (6.26%) - Sun Hung Kai Investment Services Pty Ltd (Client Honest Opport Ltd A/C) with 7,130,219 shares (3.03%). There are no ordinary shares held by Arana as treasury stock and all shares are believed to be in public hands. Refer to: |
| Details of any restrictions on the transfer of its AIM securities; | There are no jurisdictional restrictions imposed on the transfer of Arana Therapeutic Limited’s shares that Arana is currently aware of. Certain shares issued under the performance share plan to employees are the subject of a holding lock. |
| Its most recent annual report published pursuant to rule 19 and all half-yearly or similar reports published since the last annual report pursuant to rule 18; | Refer to: Annual Reports for Arana annual report for 2007 and for prior year Peptech and EvoGenix annual reports. |
| All notifications the AIM company has made in the past 12 months; | Refer to: Compliance Announcements Investor Presentations Latest News Refer also Australian Securities Exchange (ASX) website www.asx.com.au under Arana’s issuer stock code AAH and under its previous issuer code PTD. |
| Its most recent admission document together with any circulars or similar publications sent to shareholders within the past 12 months; and | Refer to: Investor Presentations Latest News For details of presentations made and other relevant matters. Also included under is the merger Scheme Booklet prepared by EvoGenix Limited, which includes “Peptech Information” prepared by Peptech, as sent to EvoGenix shareholders by EvoGenix Limited on 28 June 2007. |
| Details of its nominated adviser and other key advisers | Refer to : Corporate Directory |
| Updating of Website | Details of filings and announcements lodged on ASX and AIM are generally updated within the day of the announcement; other non-compliance details on the website are updated from time to time - the last general “non-ASX” related update of the website was in December 2007. |
| Updated 20 December 2007 | |